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ABSTRACT 
The purposes of this study were to determine the positive and negative predictive values of 
99m Technetium (99mTc) Sestamibi dual phase imaging with single photon emission 
computed tomography (SPECT) for parathyroid adenomata or hyperplasia and the effect of 
preoperative localization on duration of surgery. We reviewed 33 adults (14 men, 19 women; 
mean age 53 years) with newly diagnosed primary hyperparathyroidism who underwent neck 
exploration. The duration of surgery for this cohort was compared with a group of historical 
controls (n = 53) who underwent surgery without preoperative SPECT. At surgery, there 
were 21 adenomata (including one carcinoma), 10 patients with hyperplasia and two with no 
pathology detected. The positive predictive values (PPV) for adenomata and hyperplasia were 
95% and 100%, respectively. The negative predictive values (NPV) for these entities were 
67% and 22%, respectively. The mean weight of adenomata detected was 3.4 g (range 0.2-17 
g). Mean duration of surgery was 112.6 min as compared with 113 min in the historical 
controls (P = not significant). We conclude that 99mTc Sestamibi dual phase imaging with 
SPECT has an excellent PPV for parathyroid adenomata and hyperplasia, but does not 
contribute to reduced duration of surgery in patients undergoing neck exploration for the first 
time. The NPV is low, suggesting that a negative result does not exclude an adenoma or 
hyperplasia. 
  
Keyword: Parathyroid; Radionuclide imaging; Surgery 
  
 
